Cargando…

Oral atenolol treatment for infantile hemangiomas: clinical analysis of 133 consecutive patients

BACKGROUND: Infantile hemangiomas (IHs) are the most frequently occurring pediatric lesions. Oral propranolol has been shown to be safe and effective in infants with IHs. Side effects such as sleep disturbances have been associated with propranolol. Atenolol is a hydrophilic, selective β1-blocker an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Ze-Liang, Liu, Chao, Wang, Qi-Zhang, Wu, Hai-Wei, Zheng, Jia-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867894/ https://www.ncbi.nlm.nih.gov/pubmed/33569418 http://dx.doi.org/10.21037/atm-20-5359

Ejemplares similares

A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
por: Zhao, Ze-Liang, et al.
Publicado: (2021)

Oral atenolol therapy for proliferating infantile hemangioma: A prospective study
por: Ji, Yi, et al.
Publicado: (2016)

Oral Atenolol versus Propranolol in the Treatment of Infantile Hemangioma: A Systematic Review and Meta-Analysis
por: Pattanshetti, Swapnil Annasaheb, et al.
Publicado: (2022)

Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health
por: Hermans, Mireille M., et al.
Publicado: (2023)

Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
por: Seebauer, Caroline T., et al.
Publicado: (2022)

Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
por: Hermans, Mireille M., et al.
Publicado: (2022)

Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
por: Wu, Hai Wei, et al.
Publicado: (2018)

Correction to: Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
por: Hermans, Mireille M., et al.
Publicado: (2023)

Pharmacological therapies for infantile hemangiomas: A clinical study in 853 consecutive patients using a standard treatment algorithm
por: Zhang, Ling, et al.
Publicado: (2016)

Treatment of alarming head and neck infantile hemangiomas with interferon-α2a: a clinical study in eleven consecutive patients
por: Zhang, Ling, et al.
Publicado: (2015)

Propranolol therapy for infantile hemangioma: our experience
por: Zhang, Ling, et al.
Publicado: (2017)

Estrogen-mediated hemangioma-derived stem cells through estrogen receptor-α for infantile hemangioma
por: Zhang, Ling, et al.
Publicado: (2017)

Atenolol vs. propranolol for the treatment of infantile haemangiomas: A systematic review and meta-analysis
por: Liu, Zhuang, et al.
Publicado: (2020)

Exosome-derived miR-196b-5p facilitates intercellular interaction in infantile hemangioma via down-regulating CDKN1B
por: Wang, Qi-Zhang, et al.
Publicado: (2021)

Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma
por: HERMANS, Mireille M., et al.
Publicado: (2022)

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
por: Wu, Hai Wei, et al.
Publicado: (2017)

Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023)

Management of infantile hemangiomas: Recent advances
por: Xu, Wei, et al.
Publicado: (2022)

Oral Beta-blocker in Problematic Infantile Hemangioma
por: AlHasan, Rashed N., et al.
Publicado: (2021)

Impact of Oral β-Blockers on Surgical Treatment of Infantile Hemangioma
por: Abbas, Laielly, et al.
Publicado: (2019)

Identification of Diagnostic Markers in Infantile Hemangiomas
por: Huang, Sicong, et al.
Publicado: (2022)

Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)

Sclerotherapy for the Treatment of Infantile Hemangiomas
por: Grover, Chander, et al.
Publicado: (2012)

Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021)

Multiple Infantile Hemangiomas Treated Successfully with Oral Propranolol
por: Purkait, Radheshyam, et al.
Publicado: (2016)

Oral propranolol therapy in 23 infants with infantile hemangioma
por: Kim, Jaeyoon, et al.
Publicado: (2018)

Infantile Hemangioma Treated with Oral Propranolol: Case Presentation
por: Raufi, Nahid, et al.
Publicado: (2021)

Management of Infantile Hemangiomas
por: Reddy, Kavitha K
Publicado: (2014)

Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)

Biology of Infantile Hemangioma
por: Itinteang, Tinte, et al.
Publicado: (2014)

Approach to Infantile Hemangiomas
por: Abraham, Anil, et al.
Publicado: (2016)

Infantile Periocular Hemangioma
por: Tavakoli, Mehdi, et al.
Publicado: (2017)

Update on infantile hemangioma
por: Jung, Hye Lim
Publicado: (2021)

Engineered exosomes for targeted delivery of miR-187-3p suppress the viability of hemangioma stem cells by targeting Notch signaling
por: Zhao, Ze-Liang, et al.
Publicado: (2022)

Editorial: Advances in the medical management of infantile hemangioma
por: Wu, Haiwei, et al.
Publicado: (2023)

Comparing the Effectiveness of Propranolol versus Atenolol in Inducing Clinical Clearance in the Treatment of Infantile Haemangioma: A Randomised Controlled Trial
por: Ashraf, Raihan, et al.
Publicado: (2023)

Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study
por: Wilson, Sasha, et al.
Publicado: (2022)

Oral Propranolol in Infantile Hemangiomas: Analysis of Factors that Affect the Outcome
por: Ainipully, Arun Mohanan, et al.
Publicado: (2019)

Infantile hemangioma: timely diagnosis and treatment
por: Park, Meerim
Publicado: (2021)

Infantile Hemangiomas: An Update on Pathogenesis and Treatment
por: Kowalska, Małgorzata, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1efpkt6o7tshf1s99ljmkfijis